[jesseendahl]

BiDil actually is not a great example, because... "The trial, however, was conducted only in African American patients, and the results, therefore, give the impression that BiDil works only in African Americans. This is not the case. The trial investigators themselves concede that BiDil will work in people regardless of race." The drug company just pitched it that way to get it approved by the FDA.

Source: Kahn J (2005) From disparity to difference: How race-specific medicines may undermine policies to address inequalities in health care. South Calif Interdiscip Law J 15: 105–130.

http://128.125.42.47/why/students/orgs/ilj/assets/docs/15-1%...